Get started
Author

Jenny Shannon

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial
2016 · Pascal Hammel, Florence Huguet, et al. · JAMA · 1,126
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials
2017 · Harpreet S Wasan, Peter Gibbs, et al. · The Lancet Oncology · 413
PDF
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
2018 · Olga Kondrashova, Monique Topp, et al. · Nature Communications · 315
PDF
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial
2015 · Alexander Stein, Dirk Arnold, et al. · BMC Cancer · 243
PDF
Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study
2021 · Jeanne Tie, Yuxuan Wang, et al. · PLoS Medicine · 192
PDF
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
2025 · Jeanne Tie, Yuxuan Wang, et al. · Nature Medicine · 186
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
2020 · P. Grimison, A. Mersiades, et al. · Annals of Oncology · 169
PDF
Prognostic gene expression signature for high-grade serous ovarian cancer
2020 · J. Millstein, T. Budden, et al. · Annals of Oncology · 151
PDF
Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.
2013 · Pascal Hammel, Florence Huguet, et al. · Journal of Clinical Oncology · 112
Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.
2013 · Pascal Hammel, Florence Huguet, et al. · Journal of Clinical Oncology · 86
Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies
2018 · Peter Gibbs, Volker Heinemann, et al. · Clinical Colorectal Cancer · 71
Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
2011 · N.C. Tebbutt, F. Murphy, et al. · Annals of Oncology · 47
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
2020 · Eun Young Kang, Dane Cheasley, et al. · Modern Pathology · 45
PDF
Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial
2024 · Peter Grimison, Antony Mersiades, et al. · Journal of Clinical Oncology · 43
PDF
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
2024 · Ksenija Nesic, John J. Krais, et al. · Molecular Cancer · 42
PDF
Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysis
2016 · Dhanusha Sabanathan, Guy D. Eslick, et al. · Clinical Colorectal Cancer · 37
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy
2023 · Marjan M. Naeini, Felicity Newell, et al. · Nature Communications · 36
PDF
Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer
2020 · Mairéad Geraldine McNamara, Andre Lopes, et al. · Journal of Hepatology · 36
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer
2018 · Matthew S. Block, Robert A. Vierkant, et al. · Mayo Clinic Proceedings · 32
PDF
Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study
2013 · Pascal Hammel, Florence Huguet, et al. · Pancreatology · 32
Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma
2017 · On behalf of the INTEGRATE I investigators, Andrew J. Martin, et al. · Gastric Cancer · 26
PDF
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials
2017 · Mairéad Geraldine McNamara, John Bridgewater, et al. · BMC Cancer · 23
PDF
Quality of life in patients with K‐RAS wild‐type colorectal cancer: The CO.20 Phase 3 Randomized Trial
2013 · Jolie Ringash, Heather‐Jane Au, et al. · Cancer · 23
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer
2024 · Nikki L. Burdett, Madelynne O. Willis, et al. · Nature Communications · 21
PDF
TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer
2016 · behalf of the the Australasian Gastro-Intestinal Trials Group, D. Ferraro, et al. · Cancer Chemotherapy and Pharmacology · 17
Works count: 44
Citation count: 3,593
H-index: 23
I10-index: 28
Year
Topic
Type